MEDICARE GROUP Q.P.S.C. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.03 QAR | -0.25% |
|
-3.31% | -26.58% |
| Apr. 24 | Medicare Group Q.P.S.C. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 02 | Medicare Group Q.P.S.C. Approves Cash Dividend | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,378 | 2,488 | 1,545 | 1,139 | - | - |
| Enterprise Value (EV) 1 | 2,378 | 2,488 | 1,545 | 1,139 | 1,139 | 1,139 |
| P/E ratio | - | - | - | - | - | - |
| Yield | 3.31% | 3.17% | 4.01% | 5.46% | 5.71% | 6.95% |
| Capitalization / Revenue | 4,846,710 x | 5,218,045 x | 3,176,657 x | - | - | - |
| EV / Revenue | 4,846,710 x | 5,218,045 x | 3,176,657 x | - | - | - |
| EV / EBITDA | 23,145,373 x | 26,260,866 x | - | - | - | - |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 281,441 | 281,441 | 281,441 | 281,441 | - | - |
| Reference price 2 | 8.450 | 8.840 | 5.489 | 4.030 | 4.030 | 4.030 |
| Announcement Date | 2/6/20 | 2/24/21 | 2/20/24 | - | - | - |
1QAR in Million2QAR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales | 490.7 | 476.8 | 486.3 | - | - | - |
| EBITDA | 102.7 | 94.74 | - | - | - | - |
| EBIT | 79.98 | 71.86 | - | - | - | - |
| Operating Margin | 16.3% | 15.07% | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - |
| Net income | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share 1 | 0.2800 | 0.2800 | 0.2200 | 0.2200 | 0.2300 | 0.2800 |
| Announcement Date | 2/6/20 | 2/24/21 | 2/20/24 | - | - | - |
1QAR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | - | 128.1 | 118.9 | 109.3 | 130 |
| EBITDA | - | - | - | - | - | - |
| EBIT | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - |
| Net income | 35.45 | 20.59 | - | - | - | - |
| Net margin | - | - | - | - | - | - |
| EPS | 0.1260 | 0.0740 | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 7/20/22 | 10/21/22 | 4/18/23 | 7/18/23 | 11/7/23 | 2/20/24 |
1QAR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 23 | 36.3 | 69.8 | 78.9 | 118 |
| Net Cash position 1 | 62.6 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 0.243 x | 0.3597 x | 0.6992 x | 0.7929 x | 1.396 x |
| Free Cash Flow 1 | 60.3 | 38 | 23.8 | 5.32 | -7.96 | 2.42 |
| ROE (net income / shareholders' equity) | 8.37% | 7.67% | 8.35% | 7.68% | 7.65% | 6.4% |
| ROA (Net income/ Total Assets) | 3.94% | 3.59% | 3.74% | 3.54% | 3.42% | 2.7% |
| Assets 1 | 2,144 | 2,177 | 2,286 | 2,231 | 2,315 | 2,436 |
| Book Value Per Share 2 | 3.620 | 3.630 | 3.650 | 3.660 | 3.700 | 3.600 |
| Cash Flow per Share 2 | 0.3300 | 0.2700 | 0.2300 | 0.1900 | 0.1500 | 0.0400 |
| Capex 1 | 28.3 | 47.7 | 51.7 | 59.8 | 62.6 | 63.6 |
| Capex / Sales | 5.84% | 9.72% | 10.84% | 12.42% | 12.86% | 13.07% |
| Announcement Date | 1/31/19 | 2/6/20 | 2/24/21 | 2/21/22 | 2/21/23 | 2/20/24 |
1QAR in Million2QAR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
4.03
QAR
Average target price
5.524
QAR
Spread / Average Target
+37.07%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -26.58% | 312M | |
| -20.16% | 16.21B | |
| +4.50% | 12.44B | |
| +3.98% | 11.58B | |
| +4.63% | 10.79B | |
| +25.22% | 8.26B | |
| -0.21% | 7.68B | |
| +18.43% | 7.06B | |
| +5.07% | 6.67B | |
| +50.89% | 4.66B |
- Stock Market
- Equities
- MCGS Stock
- Financials Medicare Group Q.P.S.C.
